ConductScience.org, home

Paper36917814

Outsmarting Pathogens with Antibody Engineering.

Qerqez AN and 2 others. Annu Rev Chem Biomol Eng, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Outsmarting Pathogens with Antibody Engineering. Papers, record 36917814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36917814

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Outsmarting Pathogens with Antibody Engineering.
PubMed
Journal
Annu Rev Chem Biomol Eng
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2024-06-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qerqez ANAhlam N
2Silva RPRui P
3Maynard JAJennifer A

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
VaccinesMajor topic
Humans
Antigens
Epitopes

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI155453NIAID NIH HHSUnited StatesR01AI155453PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References145

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135058363Engineered human antibodies for the opsonization and killing of Staphylococcus aureus.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35058363PubMed
235738279Superimmunity by pan-sarbecovirus nanobodies.Cell Rep2022https://conductscience.org/library/papers/35738279PubMed
333154108Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.Science2020https://conductscience.org/library/papers/33154108PubMed
433649050Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection.Infect Immun2021https://conductscience.org/library/papers/33649050PubMed
534061593Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate.mBio2021https://conductscience.org/library/papers/34061593PubMed
625215485Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.Cell2014https://conductscience.org/library/papers/25215485PubMed
734088508A protein A based Staphylococcus aureus vaccine with improved safety.Vaccine2021https://conductscience.org/library/papers/34088508PubMed
827668287Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.JCI Insight2016https://conductscience.org/library/papers/27668287PubMed
933495308Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.Science2021https://conductscience.org/library/papers/33495308PubMed
1022042859Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/22042859PubMed
1120946259Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis.Cell Microbiol2011https://conductscience.org/library/papers/20946259PubMed
1229364906A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia.PLoS One2018https://conductscience.org/library/papers/29364906PubMed
1322734046Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.J Exp Med2012https://conductscience.org/library/papers/22734046PubMed
1419815504Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19815504PubMed
152552134A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.J Virol1989https://conductscience.org/library/papers/2552134PubMed
1631787378High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity.Cell2019https://conductscience.org/library/papers/31787378PubMed
1734942633Broadly neutralizing antibodies target a haemagglutinin anchor epitope.Nature2022https://conductscience.org/library/papers/34942633PubMed
1828469033A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants.Sci Transl Med2017https://conductscience.org/library/papers/28469033PubMed
1930343314Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial.Intensive Care Med2018https://conductscience.org/library/papers/30343314PubMed
2029099326Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.Virulence2018https://conductscience.org/library/papers/29099326PubMed

See all 145 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41187580The grand escape - how pathogens outsmart the human complement system.Immunobiology2025https://conductscience.org/library/papers/41187580PubMed
41096771Integrating Inflammatory and Epigenetic Signatures in IBD-Associated Colorectal Carcinogenesis: Models, Mechanisms, and Clinical Implications.Int J Mol Sci2025https://conductscience.org/library/papers/41096771PubMed
39039240Reprogramming human B cells with custom heavy-chain antibodies.Nat Biomed Eng2024https://conductscience.org/library/papers/39039240PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36917814

GET https://conductscience.org/api/papers/v1/36917814/references?page=2